Valuation: IRADIMED CORPORATION

Market Cap 1.18B 1.02B 955M 876M 1.65B 113B 1.67B 11.21B 4.4B 56.42B 4.44B 4.34B 187B P/E 2026 *
48.2x
P/E 2027 * 41.7x
Enterprise Value 1.18B 1.02B 955M 876M 1.65B 113B 1.67B 11.21B 4.4B 56.42B 4.44B 4.34B 187B EV / Sales 2026 *
13x
EV / Sales 2027 * 11.7x
Free-Float
64.79%
Yield 2026 *
-
Yield 2027 * -
1 day+1.41%
1 week+1.80%
Current month+1.80%
1 month-5.66%
3 months+7.20%
6 months-3.62%
Current year-4.92%
1 week 90.14
Extreme 90.14
94.73
1 month 89.51
Extreme 89.51
98.61
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/03/26 Sell

Chief Executive Officer

7,500 0.0590%
13/02/26 Sell

Director

1,000 0.0079%
26/01/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%+1.80%+32.27%+94.15% 1.18B
+1.40%-2.57%-13.89%-17.21% 13.68B
+5.40%+14.67%+52.69%+4.08% 4.47B
+1.25%+0.44%-38.58%-52.93% 1.28B
0.00%+1.50%-34.34%-39.45% 1.2B
+2.07%+1.53%-44.10% - 968M
+7.65%+24.10%+54.44%+161.87% 622M
+2.90%+7.90%+80.66% - 355M
+2.39%+1.45%-59.33%+282.31% 259M
-2.86%+19.62%+33.76%+67.72% 164M
Average +2.20%+6.21%+6.36%+62.57% 2.42B
Weighted average by Cap. +2.26%+2.10%+0.14%-1.56%

Financials

2026 *2027 *
Net sales 91.2M 78.89M 73.67M 67.58M 127M 8.68B 129M 864M 339M 4.35B 342M 335M 14.38B 101M 87.36M 81.59M 74.84M 141M 9.61B 143M 957M 376M 4.82B 379M 371M 15.93B
Net income 24.65M 21.32M 19.91M 18.27M 34.36M 2.35B 34.9M 234M 91.69M 1.18B 92.57M 90.54M 3.89B 28.45M 24.61M 22.98M 21.08M 39.65M 2.71B 40.28M 270M 106M 1.36B 107M 104M 4.49B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
07/08/26 $92.50 +1.41% 88,220
06/08/26 $91.21 -0.71% 94,438
05/08/26 $91.86 -1.36% 148,482
04/08/26 $93.13 +1.71% 227,288
03/08/26 $91.56 +0.77% 214,735
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
92.50USD
Average target price
118.00USD
Spread / Average Target
+27.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock